Leishmania donovani Infection Induces Anemia in Hamsters by Differentially Altering Erythropoiesis in Bone Marrow and Spleen

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Lafuse, William P ^a   Story, Ryan ^b   Mahylis, Jocelyn ^b   Gupta, Gaurav ^a   Varikuti, Sanjay ^a   Steinkamp, Heidi ^a   Oghumu, Steve ^a   Satoskar, Abhay R ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBULIN; BETA GLOBULIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GAMMA INTERFERON; HEMOGLOBIN; IRON; MESSENGER RNA; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOG1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ALAS2 GENE; ALPHA GLOBULIN GENE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BETA GLOBULIN GENE; BONE MARROW; BURST FORMING UNIT E; CELL DIFFERENTIATION; COLONY FORMING UNIT E; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROBLAST; ERYTHROCYTE; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; GENE; GENE EXPRESSION; HEMATOCRIT; IRON BLOOD LEVEL; LEUKOPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; SPLEEN; SYRIAN HAMSTER; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ANEMIA; ANIMALS; APOPTOSIS; BONE MARROW; CRICETINAE; ERYTHROPOIESIS; ERYTHROPOIETIN; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; SPLEEN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84875320266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059509     Document Type: Article

References (84)

1. Alexander J, Russell DG, (1992) The interaction of Leishmania species with macrophages. Adv Parasitol 31: 175-254.
2. Liew FY, O'Donnell CA, (1993) Immunology of leishmaniasis. Adv Parasitol 32: 161-258.
3. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. Lancet 366: 1561-1577.
4. Zijlstra EE, Ali MS, el-Hassan AM, el-Toum IA, Satti M, et al. (1992) Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults. J Trop Pediat 38: 17-21.
5. al-Jurayyan NA, Al-Naaer M, Al-Fawaz I, al-Herbish AS, al-Mazrou AM, et al. (1995) The haematological manifestations of visceral leishmaniasis in infancy and childhood. J Trop Pediat 41: 143-148.
6. Pearson RD, Sousa AQ, (1996) Clinical Spectrum of leishmaniasis. Clin Infect Dis 22: 1-13.
7. Santos MA, Marques RC, Fairas CA, Vasconcelos DM, Stewart JM, et al, (2002) Predictors of an unsatisfactory responses to pentavalent antimony in the treatment of American visceral leishmaniasis. Rev Soc Bras Med Trop 35: 629-633.
8. de Araujo VE, Morais MH, Reis IA, Rabello A, Carnerio M, (2012) Early clinical manifestions associated with death from visceral leishmaniasis. Plos Neg Trop Dis 6: e1511.
9. Pasaquau F, Ena J, Sanchez R, Cuadrado JM, Amador C, et al. (2005) Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. Eur J Clin Microbiol Infect Dis 24: 411-418.
10. Alvar J. Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The relationship between Leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334-359.
11. Savioli L, Daumerie D, Crompton DWT, Annon. (2010) Leishmaniasis. In: Savioli L, Daumerie D, Crompton DWT, editors. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. Geneva: World Health Organization. 91-96.
12. Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW, (1994) Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 62: 1058-1063.
13. Wilson ME, Sandor M, Blum AM, Young BM, Metwali A, et al. (1996) Local suppression of IFN-γ in hematic granulomas correlates with tissue-specific replication of Leishmania chagasi. J Immunol 156: 2231-2239.
14. Engwerda CR, Murphy M, Cotterell SE, Smelt SC, Kaye PM, (1998) Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur J Immunol 28: 669-680.
15. Engwerda CR, Kaye PM, (2000) Organ-specific immune responses associated with infectious disease. Immunology Today 21: 73-78.
16. Smelt SC, Engwerda CR, McCrossen M, Kaye PM, (1997) Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J. Immunol. 158: 3813-3821.
17. Melby PC, Tabares A, Restrepo BJ, Cardona AE, McGuff HS, et al. (2001) Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Exp Parasitol 99: 17-25.
18. Engwerda CR, Ato M, Cotterell SE, Mynott TL, Tschannerl A, et al. (2002) A role for tumor necrosis factor-α in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Path 161: 429-437.
19. Engwerda CR, Ato M, Kaye PM, (2004) Macrophages, pathology, and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 20: 524-530.
20. Ott KJ, Hanson WL, Stauber L, (1967) Course of infection of Leishmania donovani. J Parasitol 53: 641-645.
21. Farrell JP, (1976) Leishmania donovani: acquired resistance to visceral leishmaniasis in the golden hamster. Exp Parasitol 40: 89-94.
22. Gifawesen C, Farrell JP, (1989) Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect Immun 57: 3091-3096.
23. Evans TG, Smith D, Pearson RD, (1990) Humoral factors and nonspecific immune suppression in Syrian hamsters infected with Leishmania donovani. J Parasitol 76: 212-217.
24. Biswas T, Chakraborty M, Naskar K, Ghosh DK, Ghosal J, (1992) Anemia in experimental visceral leishmaniasis in hamsters. J Parsitol 78: 140-142.
25. Requena JM, Soto M, Doria MD, Alonso C, (2000) Immune and clinical parameters associated with Leishmania infantum in the golden hamster model. Vet Immunol Immunopathol 76: 269-281.
26. Zivcec M, Safronetz D, Haddock E, Feldmann H, Ebihara H, (2011) Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). J Immunol Methods 368: 24-35.
27. Melby PC, Tryon VV, Chandrasekar B, Freeman GL, (1998) Cloning of Syrian hamster (Mesocrietus auratus) cytokine cDNAs and analysis of cytokine mRNA in experimental visceral leishmaniasis. Infect Immun 66: 2135-2142.
28. Melby PC, Chandrasekar B, Zhao W, Coe JE, (2001) The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent TH1-like cytokine response. J Immunol 166: 1912-1920.
29. Cotterell SE, Engwerda CR, Kaye PM, (2000) Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani. Infect Immun 68: 1840-1848.
30. Cotterell SE, Engwerda CR, Kaye PM, (2000) Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-α. Blood 95: 1642-1651.
31. Perry J, Harandi OF, Paulson R, (2007) BMP4, SCF, and Hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors. Blood 109: 4494-4502.
32. Perry JM, Harandi OF, Porayette P, Hedge S, Kannan AK, et al. (2009) Maintenance of the BMP4 dependent stress erythropoiesis pathway in the murine spleen requires hedgehog signaling. Blood 113: 911-918.
33. Sasaki R, Masuda S, Nago M, (2000) Erythropoietin: multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem 64: 1775-1793.
34. Morceau F, Dicato M, Diecherich M, (2009) Pro-inflammatory cytokine-mediated anemia: Regarding molecular mechanisms of erythropoiesis. Mediators Inflamm 2009: 405016.
35. Zauli G, Secchiero P, (2006) The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev 17: 245-257.
36. Silvestris F, Cafforio P, Tucci M, Dammacco F, (2002) Negative regulation of erythroblast maturation by Fas-L+/TRAIL+ highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. Blood 99: 1305-1313.
37. Felli N, Pedini F, Zeuner A, Petrucci E, Testa U, et al. (2005) Multiple members of the TNF superfamily contribute to IFN-γ-mediated inhibition of erythropoiesis. J Immunol 175: 1464-1472.
38. Armeanu S, Buhring HJ, Reuss-Borst M, Muller CA, Klein G, (1995) E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol 131: 243-249.
39. Lammers R, Giesert C, Grunebach F, Marxer A, Vogel W, et al. (2002) Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis. Exp Hematol 30: 537-545.
40. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, et al. (1986) New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154: 1003-1011.
41. Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, et al. (1986) A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154: 639-649.
42. Wilson ME, Jeronimo SM, Pearson RD, (2005) Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Patho 38: 147-160.
43. El Hassan AM, Zijlstra EE, Ismael A, Ghalib HW, (1995) Recent observations on the epidemiology of kala-azar in the eastern and central states of Sudan. Trop Geogr Med 47: 151-157.
44. Ibrahim ME, Lambson B, Yousif AO, Deifalla N, Alnaiem DA, et al. (1999) Kala-azar in a high transmission foci: an ethnic and geographical dimension. AM J Trop Med Hyg 61: 941-944.
45. Testa U, (2004) Apoptotic mechanisms in the control of erythropoiesis. Leukemia 18: 1176-1199.
46. Wickramasinghe SN, Abdalla SH, Kasili EG, (1987) Ultrastructure of bone marrow in patients with visceral leishmaniasis. J Clin Pathol 40: 267-275.
47. Yarali N, Fisgin T, Duru F, Kara A, (2002) Myelodysplastic features in visceral leishmaniasis. Am J Hematol 71: 191-205.
48. Kumar PV, Vasei M, Sadeghipour A, Sadeghi E, Soleimanpour H, et al. (2007) Visceral leishmaniasis: bone marrow biopsy findings. J Pediatr Hematol Oncol 29: 77-80.
49. Hasle H, (1994) Myelodysplastic syndromes in childhood-classification, epidemiology, and treatment. Leuk Lymphoma 13: 11-16.
50. Hofmann WK, Ottmann OG, Ganser A, Hoelzer D, (1996) Myelodysplastic syndromes: clinical features. Semin Hematol 33: 177-185.
51. Sen G, Mukhopadhyay R, Ghosal J, Biswas T, (2001) Oxidative damage of erythrocytes: a possible mechanism for premature hemolysis in experimental visceral lesihmaniasis in hamsters. Ann Hematol 80: 32-37.
52. Sen G, Mukhopadhyay R, Ghosal J, Biswas T, (2004) Combination of ascorbate and α-tocopherol as a preventive therapy against structural and functional defects of erythrocytes in visceral leishmaniasis. Free Radic Res 38: 527-534.
53. Saha Roy S, Chowdhury KD, Sen G, Biswas T, (2009) Oxidation of hemoglobin and redistribution of band 3 promote erythrophagocytosis in visceral leishmaniasis. Mol Cell Biochem 321: 53-63.
54. Wu H, Klingmuller U, Acurio A, Hsiao JG, Lodish HF, (1997) Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci U S A 94: 1806-1810.
55. Munugalavadla V, Kapur R, (2005) Role of c-Kit and erythropoietin receptor in erythropoiesis. Crit Rev Onc/Hematol 54: 63-75.
56. Leonard M, Brice M, Engel JD, Papayannopoulou T, (1993) Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 82: 1071-1079.
57. Tsang AP, Fujiwara Y, Horn DB, Orkin SH, (1998) Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev 12: 1176-1188.
58. Ohneda K, Yamamoto M, (2002) Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of the red blood cell lineage. Acta Haematol 108: 237-245.
59. Ferreira R, Ohneda K, Yamamoto M, Philipsen S, (2005) GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol 25: 1215-1227.
60. Claessens YE, Bouscary D, Dupont JM, Picard F, Melle J, et al. (2002) In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood 99: 1594-1601.
61. Zang Y, Goodwin RG, Loken MR, Bryant E, Deeg HJ, et al. (2001) Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood 98: 3058-3065.
62. Campioni D, Secchiero P, Corallini F, Melloni E, Capitani S, et al. (2005) Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes. Am J Pathol 166: 557-563.
63. Liu Y, Pop R, Sadegh C, Brugnara C, Haase VH, et al. (2006) Supression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood 108: 123-133.
64. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW, (2000) Visceral leishmaniais in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 68: 6289-6293.
65. Dufour C, Corcione A, Svahn J, Haupt R, Poggi V, et al. (2003) TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anemia patients and TNFα suppresses erythropoiesis in vitro. Blood 102: 2053-2059.
66. Buck I, Morcau F, Cristofanon S, Heintz C, Chateauvieux S, et al. (2008) Tumor necrosis factor α inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and Fog-1 downregulaton and GATA-2 upregulation Biochem Pharm. 76: 1229-1239.
67. Oehler L, Kollars M, Bohle B, Berer A, Reiter E, et al. (1999) Interleukin-10 inhibits burst-forming unit-erythroid growth by suppression of endogenous granulocyte-macrophage colony-stimulating factor production from T cells. Exp Hematol 27: 217-223.
68. Zermati Y, Fichselson S, Valensi F, Freyssinier JM, Rouyer-Fessard P, et al. (2000) Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol 28: 885-894.
69. Rodrigues V Jr, Santana da Silva J, Campos-Neto A, (1998) Transforming growth factor β and immunosuppression in experimental visceral leishmaniasis. Infect Immun 66: 1233-1236.
70. Banerjee R, Kumar S, Sen A, Mookerjee A, Mukherjee P, et al. (2010) TGF-β-regulated tyrosine phosphatases induce lymphocyte apoptosis in Leishmania donovani-infected hamsters. Immunol Cell Biol 89: 466-474.
71. Hailu A, van der Poll T, Berhe N, Kager PA, (2004) Elevated plasma levels of interferon (IFN)-γ, IFN-γ inducing cytokines, and IFN-γ inducible CXC chemokines in visceral leishmaniasis. Am J Trop Med Hyg 71: 561-567.
72. Cadlas A, Favali C, Aquino D, Vinhas V, van Weyenbergh J, et al. (2005) Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infec Dis 5: 113.
73. Ansari NA, Saluja S, Salotra P, (2006) Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin Immunol 119: 339-345.
74. Mamus SW, Beck-Schroeder S, Zanjani ED, (1985) Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes. J Clin Invest 75: 1496-1503.
75. Selleri C, Maciejewski JP, Sato T, Young NS, (1996) Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87: 4149-4157.
76. Dai C, Krantz SB, (1999) Interferon gamma induces upregulation and activation of caspases 1,3 and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93: 3309-3316.
77. Caux C, Moreau I, Saeland S, Bancherau J, (1992) Interferon-γ enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic cells. Blood 79: 2628-2635.
78. Zhao X, Ren G, Liang L, Ai PZ, Zheng B, et al. (2010) Brief Report: Interferon-γ induces expransion of Lin-Sca-1+C-Kit+ cells. Stem Cells 28: 122-126.
79. Rebouche CJ, Wilcox CL, Widness JA, (2004) Microanalysis of non-heme iron in animal tissues. J Biochem Biophys Methods. 58: 239-51.
80. Worthington RE, (1987) Quantitation of erythroid differentiation in vitro using a sensitive colorimetric assay for hemoglobin. Exp Hematol 15: 85-92.
81. Pacheco-Yepez J, Galvan-Moroyoqui JM, Meza I, Tsutsumi V, Shibayama M, (2011) Expression of cytokines and their regulation during amoebic liver abscess development. Parasite Immunol. 33: 56-64.
82. Rama Iniguez S, Dea-Ayuela MA, Sanchez-Brunete JA, Torrado JJ, Alunda JM, et al. (2006) Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation. Antimicrob Agents Chemother 50: 1195-1201.
83. Li G, Duan T, Wu X, Tesh RB, Soong L, et al. (2008) Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathological changes. Int J Clin Exp Pathol 1: 169-179.
84. Livak KJ, Schmittgen DT, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25: 402-408.